<?xml version="1.0" encoding="UTF-8"?>
<p>In consideration of worldwide attention to recent ZIKV outbreaks, many efforts have been made to explore potential effective therapies. Currently, there is no approved practicable prophylactic vaccine, and eliminating 
 <italic>Aedes</italic>, the main vector of ZIKV, remains the primary preventive measure. The high throughput screening of already-approved drugs has been carried out to provide anti-ZIKV drug candidates [
 <xref rid="B41-viruses-11-01064" ref-type="bibr">41</xref>,
 <xref rid="B42-viruses-11-01064" ref-type="bibr">42</xref>,
 <xref rid="B43-viruses-11-01064" ref-type="bibr">43</xref>]. By using this method, we found a potent inhibitor, Ery-Est, against ZIKV.
</p>
